Omnicell (OMCL) Q4 Earnings Lag Estimates

分组1 - Omnicell reported quarterly earnings of $0.4 per share, missing the Zacks Consensus Estimate of $0.47 per share, and down from $0.6 per share a year ago, representing an earnings surprise of -15.34% [1] - The company posted revenues of $313.98 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 0.14%, and up from $306.88 million year-over-year [2] - Omnicell has surpassed consensus EPS estimates three times over the last four quarters and topped consensus revenue estimates four times in the same period [2] 分组2 - The stock's immediate price movement will depend on management's commentary during the earnings call, with Omnicell shares up about 3.1% year-to-date compared to the S&P 500's gain of 0.5% [3] - The current consensus EPS estimate for the coming quarter is $0.33 on revenues of $277.09 million, and for the current fiscal year, it is $1.80 on revenues of $1.21 billion [7] - The Zacks Industry Rank indicates that the Medical Info Systems sector is currently in the bottom 40% of over 250 Zacks industries, which may impact stock performance [8]